Professional
Added to YB: 2025-09-18
Pitch date: 2025-08-19
AZTA [neutral]
Azenta, Inc.
+17.9%
current return
Author Info
No bio for this author
Company Info
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Market Cap
$1.4B
Pitch Price
$29.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
17.56
P/E
-8.26
EV/Sales
1.32
Sector
Life Sciences Tools and Services
Category
N/A
Prosper Stars & Stripes Exited Short Position: Azenta, Inc.
AZTA covered short: Life sciences co w/ sample mgmt (48% sales) & multiomics (39% sales). Red flag: sub-7% EBIT margins vs 15%+ expected for sector. Facing NIH spending cuts, tough biotech funding, China weakness, mRNA/CGT uncertainty. Covered short after ~40% decline.
Read full article (1 min)